INBRAIN Neuroelectronics cierra una ronda Series A de más de €14M liderada por Asabys Partners, Alta Life Sciences y CDTI para desarrollar terapias neuroelectrónicas inteligentes basadas en grafeno para trastornos cerebrales [...]
INBRAIN Neuroelectronics raises over €14M Series A led by Asabys Partners, Alta Life Sciences and CDTI to develop intelligent graphene-based neuroelectronic therapies for brain related disorders [...]
ONA Therapeutics appoints Mark Throsby to its Board of Directors Ona Therapeutics, a company focused on the discovery and development of therapeutic biologics to treat metastatic [...]
MedLumics closes upsized EUR 18M (21.7M USD) financing round and appoints new Chairman MedLumics’ oversubscribed financing round closes at EUR 18M to advance optically-guided real-time ablation catheter technology for the [...]
Koa Health Closes Oversubscribed €30M Series A to Accelerate Growth Following Spinout From Telefónica The digital mental healthcare provider will use funds to accelerate product development, expand [...]
Splice Bio appoints Jean-Philippe Combal as Chairman of the Board of Directors Splice Bio, a gene therapy company based on technology [...]
ProteoDesign anuncia una nueva ronda de financiación liderada por Ysios Capital y renueva su marca bajo el nombre de Splice Bio [...]
Digital therapeutics leader Sidekick raises $20M in Series A funding round led by Wellington and Asabys Sidekick Health operates a gamified digital care platform for multiple therapeutic areas [...]
Asabys y Wellington lideran una ronda de financiación de $20M en Sidekick Sidekick opera una plataforma de salud digital que permite desarrollar programas terapéuticos para tratar múltiples patologías [...]
Medlumics raises €14M in a Series E financing co-led by Asabys Partners, VI Partners and CDTI Innvierte, together with existing investors Andera Partners, Caixa Capital Risc and Innogest Medlumics [...]
